Financial Statements/ESG Information - [Interim/Half-Year Report]

OrbusNeich Medical Group Holdings Limited operates as a medical device manufacturer. The Company develops, manufactures, and distributes interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. OrbusNeich Medical Group Holdings markets its products in Asia, Europe, America, and other countries and regions.

OrbusNeich Medical Group Holdings (6929 HK)

Interim Report 2025

Announcements and Notices - [Dividend or Distribution (Announcement Form)]

Declaration Of Special Dividend And Closure Of Register Of Members

Announcements and Notices - [Interim Results / Dividend or Distribution / Closure of Books or Change of Book Closure Period]

Announcement Of Interim Results For The Six Months Ended June 30, 2025

Announcements and Notices - [Date of Board Meeting]

Date Of Board Meeting

Announcements and Notices - [Terms of Reference of the Nomination Committee]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Interim Report 2025

Declaration Of Special Dividend And Closure Of Register Of Members

Announcement Of Interim Results For The Six Months Ended June 30, 2025

Date Of Board Meeting

Terms Of Reference Of The Nomination Committee